SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Lucent Technologies (LU) -- Ignore unavailable to you. Want to Upgrade?


To: Jim Rokosh who wrote (1464)3/1/1998 5:14:00 AM
From: RavBruce  Read Replies (2) | Respond to of 21876
 
Although I continue to be bullish about Lucent
over the long term, I am willing to stick my
neck out a bit and say that I am concerned about
the recent rise. It has put Lucent at ratios
far out of league of where they should be.
I think Lucent deserves a premium to the market
for their quality of research, management, etc.
but it is a little rediculous.
In a NY times article on Friday, a management member
(in finance but I can't remember their position)
compared them to Merck(one of my favorate long-term stocks)
in terms of R&D, quality of revenue growth etc. The
problem with the comparison is if they sold at the same
multiple(even after Mercks very sharp rise in recent
weeks), Lucent would sell at 89!!!! Lucents P/E is over
99 according to todays NY Times!!!!! That is unwarranted
by their current story and size.
Also, Lucent has reached many analysts 98 targets by
mid Feb. Although I will not bet money or short my
shares--I think Lucent may end the year only a little higher
than where it is now and there will be a pull-back to
@100 after the split hysteria dies down.
This is barring any major, unpredicted news by Lucent.
Sorry to crash the party,
Bruce